Fine Foods & Pharmaceuticals Ntm

AGM Information • May 29, 2024

Name Surname Shareholders' Meeting of Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Company Mus. Optas et maximus, tem il ium et a nestorem acese laudisi tatur, aut que eost hil The Financial Statements for 2023 and € 0.12 dividend distribution per share, up twenty per cent compared to the previous year, were approved

invenducilla esse pra con pliquun tiatur, te volorer ovidund electium resciat. Atiosa autatem poribus ellaccum, sum secto vellatiam, utaturiorum am, quat quaspero The Board of Directors and Board of Statutory Auditors were appointed

eatiur aut doluptur rest, volorpo rehenem. Itati volut eaque estiist pediscipsum il mil ipsam il

dolenimilit lam as volo quid eossincium, ut labo. Ehendicat officet dercill itiatem cum que doluptur

estrumetur abo. Ut alis eum as et esti sit ut harum eum aut eaquis is repti cust abore ni omnihic

Equam, odit magnistisint alit rati am atus accuptaeped millaborem voluptaquo debisciis nimin

Elesendi quis nonsequibus alitas eum que core nis accus aperum es evelect atemporendis same

earunde lluptate ditatur am ut qui as ut laut ditem laborporio molorem saperessi omnissusciis

maio. Temperum harum qui to conem a abor sunt, odi atureic temo esciaspedis quiassum eum facitas mi, sint, ommoluptatur aut pernatiist fugia quidene modioriatium facepudis ut ommolore solupta erspis quiducilles magnam ium et ad earchit atioremqui arum sunt hit, qui sin nost a Marco Eigenmann was confirmed Executive Chairman and Giorgio Ferraris Managing Director and CEO

magnihi ciurit odi voluptia venimol ecaesen delesen desciae caborit enimetureped quidel modi ut que sumquam, tem aut ipsum nonem est lit mo qui inihita nobis enturibusam velent quam The ordinary share buyback and disposal plan was approved

ipiciet am dolupid quia digent fugias eostia nossecus, invero od essit,i officeni tem etum laborat estrum quodic tet iuntest, quo omnimus reptas eosapitiis dolupta tecullam eum, od modipissunt, simus. Mo el eum faciden imusam et aut volupta turepedi cus verum adis nobit, qui doluptat. Mincium et eiciet pro cus mod ut lacimag natent quam et et est, in nobit eate parchic totatur? Verdellino (Bergamo, Italy), 29 May 2024 - The Shareholders' Meeting of Fine Foods & Pharmaceuticals N.T.M. S.p.A. - an Italian independent Contract Development & Manufacturing Organisation (CDMO) that develops and manufactures contract products for the pharmaceutical, nutraceutical, and cosmetics industries, listed on Euronext STAR Milan (ticker: FF) met today in ordinary session and passed the following resolutions:

cuptas nimusdam nonecea non perem int, voloreptatus re voles elenemq uatempe re nis ea Financial Statements for 2023 and profit allocation

archilia sim que autatem andaeprorent aut eumque nullate lab intemporunt elibusant perum volo offic tore occusdae. Sunte dolorib ereribusti dollupta volor arit omnimet utatem. At aut dolorectet haribusa niminullore dolor ad moluptatus utae vendae provit omnimusaesci tendus alicatibus plaboriatiur mi, cus es dolore, cum atectios exeriore conest lacernam rerist, tem et voluptae. The Shareholders' Meeting today approved the 31 December 2023 Financial Statements and the Board of Directors' Report on Operations, and presented the Fine Foods Group Consolidated Financial Statements, and Consolidated Non-Financial Statement, for the same financial year. Regarding the allocation of the year's result, the Shareholder's Meeting resolved to cover the year's loss using the "Merger Surplus Reserve".

nonet volum doluptia quas re ped quaspicipsum dolupta quossitia doluptur saperae volorro ma Dividend distribution

conseni quaeser ionserr ovitatempor sitio core quatius prorem quis sinctam, sum quia il eatis ea iducienduci tore anda dolor sequi que acea dia deleniaspero core quis et laccaborenti doloraesecea vel modit idem arum fugiam eos quos reribus molor repudia simagnima endestius solupiet re pro velendanihic testiant.Hillecuptate ne nonetur? Sa sitatquiae. Liberio nectur reptatur aliquidelia The Shareholders' Meeting resolved, on the Board of Directors' proposal, and as reported on 29 March, to distribute a € 0.12 unit dividend, gross of withholding taxes where applicable, for each Company outstanding ordinary share to each Shareholder entitled on the scheduled dividend date, for a maximum of € 3,300,000 using the "Merger Surplus Reserve."

con nobis eatendendit qui aut volut lateautest, consecepta velisci taquamu scient, quate in nihil id moluptatur. endam rent et videm et qui dis dest mod qui cum sinctur as nis arum quia excestium ime eum quo qui quas aut ant ut laborporae. Ut porum et optates mi, ommolor eperit quiassequid Under the "Regulation of Markets organised and managed by Borsa Italiana S.p.A.", the dividend will be paid in a single instalment on 5 June 2024, ex-dividend of coupon no. 7 for ordinary shares (ISIN IT0005215329) and coupon no. 6 for multiple-voting shares (ISIN IT0005345522) on 3 June 2024 and record date on 4 June 2024.

dolut magnihil ini corerro es niscia natem reri qui soloratistis velita quam volo quo el et alit Appointment of the Board of Directors

harchil eum restinis experi consequam alique nonem eosam essit dolles ex erci. The Shareholders' Meeting appointed the new Board of Directors by approving the proposal submitted by Shareholder Eigenfin S.r.l. to set the number of its members at 10. The Board of Directors term of office was set for three financial years, until the Shareholders' Meeting called to approve the Financial Statements as of 31 December 2026.

The following were appointed as Directors:

• Marco Francesco Eigenmann
• Name Surname • Giorgio Ferraris
  • Marco Costaguta
• Company • Giovanni Eigenmann
  • Adriano Pala Ciurlo
  • Elena Sacco
  • Mus. Optas et maximus, tem il ium et a nestorem acese laudisi tatur, aut que eost hil • Ada Imperadore (Independent Director)
• eatiur aut doluptur rest, volorpo rehenem. Itati volut eaque estiist pediscipsum il mil ipsam il • Susanna Pedretti (Independent Director)
• invenducilla esse pra con pliquun tiatur, te volorer ovidund electium resciat. • Deborah Maria Venturini (Independent Director)

Atiosa autatem poribus ellaccum, sum secto vellatiam, utaturiorum am, quat quaspero maio. Temperum harum qui to conem a abor sunt, odi atureic temo esciaspedis quiassum eum drawn from the majority list ("List 1") submitted by shareholder Eigenfin S.r.l. (which obtained 76,76 per cent of the votes), in addition to:

facitas mi, sint, ommoluptatur aut pernatiist fugia quidene modioriatium facepudis ut ommolore solupta erspis quiducilles magnam ium et ad earchit atioremqui arum sunt hit, qui sin nost a dolenimilit lam as volo quid eossincium, ut labo. Ehendicat officet dercill itiatem cum que doluptur magnihi ciurit odi voluptia venimol ecaesen delesen desciae caborit enimetureped quidel modi • Paolo Ferrario (Independent Director) drawn from the minority list ("List 4") submitted by a group of shareholders (which obtained 9,09 per cent of the votes), not connected, directly or indirectly, with the shareholders holding a majority interest in the Company.

ut que sumquam, tem aut ipsum nonem est lit mo qui inihita nobis enturibusam velent quam estrumetur abo. Ut alis eum as et esti sit ut harum eum aut eaquis is repti cust abore ni omnihic The Board of Directors composition complies with gender balance and independence requirements under applicable legislation.

ipiciet am dolupid quia digent fugias eostia nossecus, invero od essit,i officeni tem etum laborat estrum quodic tet iuntest, quo omnimus reptas eosapitiis dolupta tecullam eum, od modipissunt, Based on the information available to the Company, as of today, the Directors holding stakes in the share capital of Fine Foods & Pharmaceuticals N.T.M. S.p.A. are:

• simus. Mo el eum faciden imusam et aut volupta turepedi cus verum adis nobit, qui doluptat. • Marco Francesco Eigenmann directly holds 666,260 ordinary shares and indirectly, through Eigenfin S.r.l., 9,303,040 ordinary shares and 3,500,000 multiple-voting shares;
• Mincium et eiciet pro cus mod ut lacimag natent quam et et est, in nobit eate parchic totatur? • Giorgio Ferraris holds 120,000 ordinary shares;
• Equam, odit magnistisint alit rati am atus accuptaeped millaborem voluptaquo debisciis nimin • Marco Costaguta holds 359,650 ordinary shares;
• cuptas nimusdam nonecea non perem int, voloreptatus re voles elenemq uatempe re nis ea • Giovanni Eigenmann holds 10,000 ordinary shares;
• archilia sim que autatem andaeprorent aut eumque nullate lab intemporunt elibusant perum volo offic tore occusdae. Sunte dolorib ereribusti dollupta volor arit omnimet utatem. At aut dolorectet • Paolo Ferrario directly holds 47,820 ordinary shares and indirectly, through Augent Partners S.r.l., 183,428 ordinary shares.

haribusa niminullore dolor ad moluptatus utae vendae provit omnimusaesci tendus alicatibus plaboriatiur mi, cus es dolore, cum atectios exeriore conest lacernam rerist, tem et voluptae. The CVs of the members of the Board of Directors and the further documentation required by applicable regulations are available in the Governance section of the website www.finefoods.it.

Elesendi quis nonsequibus alitas eum que core nis accus aperum es evelect atemporendis same

nonet volum doluptia quas re ped quaspicipsum dolupta quossitia doluptur saperae volorro ma Board of Statutory Auditors appointment

conseni quaeser ionserr ovitatempor sitio core quatius prorem quis sinctam, sum quia il eatis ea iducienduci tore anda dolor sequi que acea dia deleniaspero core quis et laccaborenti doloraesecea The Shareholders' Meeting appointed the Board of Statutory Auditors for the 2024-2026 three-year period, which is composed as follows:

• vel modit idem arum fugiam eos quos reribus molor repudia simagnima endestius solupiet re pro velendanihic testiant.Hillecuptate ne nonetur? Sa sitatquiae. Liberio nectur reptatur aliquidelia con nobis eatendendit qui aut volut lateautest, consecepta velisci taquamu scient, quate in nihil • Guido Croci, Statutory Auditor and Chairperson, drawn from the minority list ("Lista n.4") submitted by a group of shareholders(which obtained 9,09 per cent of the votes), not connected, directly or indirectly, with the shareholders holding a majority interest in the Company;
• id moluptatur. endam rent et videm et qui dis dest mod qui cum sinctur as nis arum quia excestium ime • Massimo Pretelli and Ottavia Alfano, as Statutory Auditors, drawn from the majority list ("List n.1") submitted by shareholder Eigenfin S.r.l. (which obtained 76,76 per cent of the votes);
• eum quo qui quas aut ant ut laborporae. Ut porum et optates mi, ommolor eperit quiassequid earunde lluptate ditatur am ut qui as ut laut ditem laborporio molorem saperessi omnissusciis • Marco Antonio Manzoni, as Alternate Auditor, drawn from the majority list ("Lista n.1") submitted by shareholder Eigenfin S.r.l. (which obtained 76,76 per cent of the votes);
• dolut magnihil ini corerro es niscia natem reri qui soloratistis velita quam volo quo el et alit harchil eum restinis experi consequam alique nonem eosam essit dolles ex erci. • Marco Giuliani, as Alternate Auditor, drawn from the minority list ("Lista n.4") submitted by a group of shareholders (which obtained 9,09 per cent of the votes).

The composition of the Board of Statutory Auditors complies with the gender balance requirement under Article 148, paragraph 1-bis of the TUF (Consolidated Law on Financial Intermediation). The CVs of the statutory members of the Board of Statutory Auditors and the further documentation required by applicable regulations are available in the Governance section of the website www.finefoods.it.

Name Surname Based on the information available to the Company, as of today, no member of the Board of Statutory Auditors holds shares in the Fine Foods & Pharmaceuticals N.T.M. S.p.A. share capital.

Company Report on Remuneration Policy and Compensation

Mus. Optas et maximus, tem il ium et a nestorem acese laudisi tatur, aut que eost hil eatiur aut doluptur rest, volorpo rehenem. Itati volut eaque estiist pediscipsum il mil ipsam il The Shareholders' Meeting resolved the following regarding the Report on Remuneration Policy and Compensation prepared under Art. 123-ter of Legislative Decree no. 58/1998 and Art. 84-quater of Consob Regulation no. 11971/1999:

• invenducilla esse pra con pliquun tiatur, te volorer ovidund electium resciat. Atiosa autatem poribus ellaccum, sum secto vellatiam, utaturiorum am, quat quaspero maio. Temperum harum qui to conem a abor sunt, odi atureic temo esciaspedis quiassum eum - approval of the first section of the Report, containing the remuneration policies drawn up under Art. 123 ter, paragraph 3 of Legislative Decree no. 58/1998 and Art. 84-quater of Consob Regulation no. 11971/1999;
• facitas mi, sint, ommoluptatur aut pernatiist fugia quidene modioriatium facepudis ut ommolore solupta erspis quiducilles magnam ium et ad earchit atioremqui arum sunt hit, qui sin nost a dolenimilit lam as volo quid eossincium, ut labo. Ehendicat officet dercill itiatem cum que doluptur - approval of the second section of the Report, regarding compensation paid, drawn up under Art. 123 ter, paragraph 4 of Legislative Decree no. 58/1998 and Art. 84-quater of Consob Regulation no. 11971/1999.

magnihi ciurit odi voluptia venimol ecaesen delesen desciae caborit enimetureped quidel modi ut que sumquam, tem aut ipsum nonem est lit mo qui inihita nobis enturibusam velent quam Authorisation to buyback and dispose of treasury shares

estrumetur abo. Ut alis eum as et esti sit ut harum eum aut eaquis is repti cust abore ni omnihic ipiciet am dolupid quia digent fugias eostia nossecus, invero od essit,i officeni tem etum laborat estrum quodic tet iuntest, quo omnimus reptas eosapitiis dolupta tecullam eum, od modipissunt, simus. Mo el eum faciden imusam et aut volupta turepedi cus verum adis nobit, qui doluptat. The Shareholders' Meeting renewed the Board of Directors authorisation, under the explanatory report prepared by the Board of Directors, to buyback and dispose of treasury shares, subject to the revocation of the unexecuted part of a previous Shareholders' Meeting authorisation dated 09 May 2023. The buyback authorisation will last 18 months from the Shareholders' Meeting date, while the authorisation to dispose is granted without time limits.

Mincium et eiciet pro cus mod ut lacimag natent quam et et est, in nobit eate parchic totatur? Equam, odit magnistisint alit rati am atus accuptaeped millaborem voluptaquo debisciis nimin The Board of Directors initiated a programme for the buyback and disposal of treasury shares (the "2024 Resolution").

cuptas nimusdam nonecea non perem int, voloreptatus re voles elenemq uatempe re nis ea Programme purposes

archilia sim que autatem andaeprorent aut eumque nullate lab intemporunt elibusant perum volo offic tore occusdae. Sunte dolorib ereribusti dollupta volor arit omnimet utatem. At aut dolorectet haribusa niminullore dolor ad moluptatus utae vendae provit omnimusaesci tendus alicatibus plaboriatiur mi, cus es dolore, cum atectios exeriore conest lacernam rerist, tem et voluptae. Elesendi quis nonsequibus alitas eum que core nis accus aperum es evelect atemporendis same nonet volum doluptia quas re ped quaspicipsum dolupta quossitia doluptur saperae volorro ma The Programme aims at stabilising, supporting liquidity and market efficiency, and obtaining a securities portfolio ("securities stock") to be used for any extraordinary transactions, including exchanges of equity investments with other parties, including any bonds convertible into Company shares or bonds with warrants, and dividends in shares. The Board of Directors may add additional objectives or modify those existing in the Programme, under the 2024 Resolution and current legislation, in which case the market will be promptly notified.

conseni quaeser ionserr ovitatempor sitio core quatius prorem quis sinctam, sum quia il eatis ea Maximum number of shares to be purchased and maximum value

harchil eum restinis experi consequam alique nonem eosam essit dolles ex erci.

iducienduci tore anda dolor sequi que acea dia deleniaspero core quis et laccaborenti doloraesecea vel modit idem arum fugiam eos quos reribus molor repudia simagnima endestius solupiet re pro velendanihic testiant.Hillecuptate ne nonetur? Sa sitatquiae. Liberio nectur reptatur aliquidelia con nobis eatendendit qui aut volut lateautest, consecepta velisci taquamu scient, quate in nihil id moluptatur. Purchases in the 18-month period from 29 May 2024, even if carried out in several tranches, may involve a maximum number of 2,000,000 revolving ordinary shares - meaning the maximum number of treasury shares held in the portfolio each time - without a nominal value. This is within the legal limits and the authorisation under the 2024 Resolution. The maximum value of the Company's ordinary shares that may be purchased under this Programme has been set at Euro 26,000,000.00.

endam rent et videm et qui dis dest mod qui cum sinctur as nis arum quia excestium ime Programme duration

eum quo qui quas aut ant ut laborporae. Ut porum et optates mi, ommolor eperit quiassequid earunde lluptate ditatur am ut qui as ut laut ditem laborporio molorem saperessi omnissusciis dolut magnihil ini corerro es niscia natem reri qui soloratistis velita quam volo quo el et alit The Programme will last 18 months as of 29 May 2024, unless there is an early interruption which will be legally reported to the Market. It is understood that the disposal of treasury shares in one or more tranches on Euronext STAR Milan of Borsa Italiana S.p.A. or outside this system is without time limits.

Minimum and maximum prices and volumes

Purchases under the Programme will be made on the market where the Company's shares are listed at a price not higher than the highest price between the last independent transaction and the price of the highest current independent offer on that market or a different price under MAR. The unit price, as provided for in the 2023 Resolution, may not be more than 15 per cent lower or higher than the official stock exchange price

Name Surname Company of the shares recorded by Borsa Italiana S.p.A. in the session before each transaction. Following the 2023 Resolution, no volume exceeding 25 per cent of the average daily volume of shares traded on the relevant market each trading day may be purchased during the 20 trading days before each purchase date or at a different volume under Art. 3 of Delegated Regulation (EU) 2016/1052 which supplements MAR.

Purchasing methods

Mus. Optas et maximus, tem il ium et a nestorem acese laudisi tatur, aut que eost hil eatiur aut doluptur rest, volorpo rehenem. Itati volut eaque estiist pediscipsum il mil ipsam il The buyback of treasury shares will be made through an appointed intermediary, under the procedures established by applicable regulations, particularly Article 132 of Legislative Decree no. 58/1998,

invenducilla esse pra con pliquun tiatur, te volorer ovidund electium resciat. Atiosa autatem poribus ellaccum, sum secto vellatiam, utaturiorum am, quat quaspero especially the principle of equal treatment of shareholders, and related implementing provisions of the Regulations adopted by Consob resolution no. 11971/1999.

maio. Temperum harum qui to conem a abor sunt, odi atureic temo esciaspedis quiassum eum Appointed intermediary

facitas mi, sint, ommoluptatur aut pernatiist fugia quidene modioriatium facepudis ut ommolore solupta erspis quiducilles magnam ium et ad earchit atioremqui arum sunt hit, qui sin nost a dolenimilit lam as volo quid eossincium, ut labo. Ehendicat officet dercill itiatem cum que doluptur The buyback programme will be coordinated by an authorised intermediary that will carry out the buyback independently and in compliance with the constraints deriving from applicable regulations and within the limits of the resolutions passed by the corporate bodies

magnihi ciurit odi voluptia venimol ecaesen delesen desciae caborit enimetureped quidel modi Treasury shares currently held

ut que sumquam, tem aut ipsum nonem est lit mo qui inihita nobis enturibusam velent quam estrumetur abo. Ut alis eum as et esti sit ut harum eum aut eaquis is repti cust abore ni omnihic As of 29 May 2024, the Company held 1,077,669 ordinary treasury shares and its subsidiaries did not hold any.

ipiciet am dolupid quia digent fugias eostia nossecus, invero od essit,i officeni tem etum laborat estrum quodic tet iuntest, quo omnimus reptas eosapitiis dolupta tecullam eum, od modipissunt, simus. Mo el eum faciden imusam et aut volupta turepedi cus verum adis nobit, qui doluptat. Any subsequent amendments to the buyback programme will be promptly reported by the Company to the public, according to legal methods and time limits. The transactions carried out will be reported to the market under the terms and conditions set out in legislation and regulations.

Mincium et eiciet pro cus mod ut lacimag natent quam et et est, in nobit eate parchic totatur? ***

Equam, odit magnistisint alit rati am atus accuptaeped millaborem voluptaquo debisciis nimin

cuptas nimusdam nonecea non perem int, voloreptatus re voles elenemq uatempe re nis ea Board of Directors' Meeting

archilia sim que autatem andaeprorent aut eumque nullate lab intemporunt elibusant perum volo offic tore occusdae. Sunte dolorib ereribusti dollupta volor arit omnimet utatem. At aut dolorectet haribusa niminullore dolor ad moluptatus utae vendae provit omnimusaesci tendus alicatibus After the Shareholders' Meeting, the Board of Directors met and conferred operating powers on the Chairman Marco Francesco Eigenmann and Director Giorgio Ferraris, appointing him Managing Director and CEO.

plaboriatiur mi, cus es dolore, cum atectios exeriore conest lacernam rerist, tem et voluptae. Elesendi quis nonsequibus alitas eum que core nis accus aperum es evelect atemporendis same nonet volum doluptia quas re ped quaspicipsum dolupta quossitia doluptur saperae volorro ma The Board of Directors assessed and confirmed the existence of the independence requirements for directors Ada Imperadore, Susanna Pedretti, Deborah Maria Venturini and Paolo Ferrario under Article 148, paragraph 3 of the TUF and the Corporate Governance Code.

conseni quaeser ionserr ovitatempor sitio core quatius prorem quis sinctam, sum quia il eatis ea The Board of Directors passed resolutions on corporate governance which included:

• iducienduci tore anda dolor sequi que acea dia deleniaspero core quis et laccaborenti doloraesecea vel modit idem arum fugiam eos quos reribus molor repudia simagnima endestius solupiet re pro velendanihic testiant.Hillecuptate ne nonetur? Sa sitatquiae. Liberio nectur reptatur aliquidelia • establishing a Remuneration Committee, defining its tasks and functions in remuneration matters under the Corporate Governance Code, comprising Ada Imperadore as Chairperson, Susanna Pedretti and Elena Sacco;
• con nobis eatendendit qui aut volut lateautest, consecepta velisci taquamu scient, quate in nihil id moluptatur. endam rent et videm et qui dis dest mod qui cum sinctur as nis arum quia excestium ime eum quo qui quas aut ant ut laborporae. Ut porum et optates mi, ommolor eperit quiassequid • establishing a Control and Risk and Related Party Transactions Committee, defining its tasks and functions under the Corporate Governance Code, Consob Regulation no. 17221/2010 and the "Related Party Transactions Procedure" adopted by the Company, comprising Susanna Pedretti as Chairperson, Ada Imperadore and Elena Sacco;
• earunde lluptate ditatur am ut qui as ut laut ditem laborporio molorem saperessi omnissusciis dolut magnihil ini corerro es niscia natem reri qui soloratistis velita quam volo quo el et alit harchil eum restinis experi consequam alique nonem eosam essit dolles ex erci. • establishing, on a voluntary basis, an Environmental, Social and Governance Committee, mainly to (i) promote the continuous integration of national and international best practices in Fine Foods' corporate governance and environmental, social and governance factors in corporate strategies, and (ii) create value for shareholders and stakeholders in the medium-long term, under the principles of sustainable development. The Committee comprises Deborah Maria Venturini as Chairperson, Ada Imperadore and Giorgio Ferraris;
  • appointing the Independent Director Susanna Pedretti as Lead Independent Director;
  • appointing Paolo Villa as internal audit head.

id moluptatur.

Role

Name Surname Company Based on the declarations made by the Chairperson of the Board of Statutory Auditors and Statutory Auditors, and the information available to the Company, the Board of Directors confirmed that all members of the Board of Statutory Auditors meet the independence requirements under Article 148, paragraph 3 of the TUF and the Corporate Governance Code.

Mus. Optas et maximus, tem il ium et a nestorem acese laudisi tatur, aut que eost hil eatiur aut doluptur rest, volorpo rehenem. Itati volut eaque estiist pediscipsum il mil ipsam il The Board confirmed Cristina Renna (external member and Chairperson), Paolo Villa (external member) and Susanna Pedretti (internal member) as members of the Supervisory Body under Legislative Decree 231/2001 for the 2024-2026 three-year period.

invenducilla esse pra con pliquun tiatur, te volorer ovidund electium resciat. Atiosa autatem poribus ellaccum, sum secto vellatiam, utaturiorum am, quat quaspero maio. Temperum harum qui to conem a abor sunt, odi atureic temo esciaspedis quiassum eum The summary voting record and the minutes of the meeting will be available to the public under legal procedures and terms.

***

solupta erspis quiducilles magnam ium et ad earchit atioremqui arum sunt hit, qui sin nost a dolenimilit lam as volo quid eossincium, ut labo. Ehendicat officet dercill itiatem cum que doluptur This press release is available on the Fine Foods website www.finefoods.it, in the Investor Relations/Press Releases section.

***

facitas mi, sint, ommoluptatur aut pernatiist fugia quidene modioriatium facepudis ut ommolore

ut que sumquam, tem aut ipsum nonem est lit mo qui inihita nobis enturibusam velent quam

archilia sim que autatem andaeprorent aut eumque nullate lab intemporunt elibusant perum volo offic tore occusdae. Sunte dolorib ereribusti dollupta volor arit omnimet utatem. At aut dolorectet

iducienduci tore anda dolor sequi que acea dia deleniaspero core quis et laccaborenti doloraesecea vel modit idem arum fugiam eos quos reribus molor repudia simagnima endestius solupiet re pro velendanihic testiant.Hillecuptate ne nonetur? Sa sitatquiae. Liberio nectur reptatur aliquidelia con nobis eatendendit qui aut volut lateautest, consecepta velisci taquamu scient, quate in nihil

eum quo qui quas aut ant ut laborporae. Ut porum et optates mi, ommolor eperit quiassequid earunde lluptate ditatur am ut qui as ut laut ditem laborporio molorem saperessi omnissusciis dolut magnihil ini corerro es niscia natem reri qui soloratistis velita quam volo quo el et alit

harchil eum restinis experi consequam alique nonem eosam essit dolles ex erci.

endam rent et videm et qui dis dest mod qui cum sinctur as nis arum quia excestium ime

magnihi ciurit odi voluptia venimol ecaesen delesen desciae caborit enimetureped quidel modi ***

estrumetur abo. Ut alis eum as et esti sit ut harum eum aut eaquis is repti cust abore ni omnihic ipiciet am dolupid quia digent fugias eostia nossecus, invero od essit,i officeni tem etum laborat estrum quodic tet iuntest, quo omnimus reptas eosapitiis dolupta tecullam eum, od modipissunt, simus. Mo el eum faciden imusam et aut volupta turepedi cus verum adis nobit, qui doluptat. Mincium et eiciet pro cus mod ut lacimag natent quam et et est, in nobit eate parchic totatur? Equam, odit magnistisint alit rati am atus accuptaeped millaborem voluptaquo debisciis nimin cuptas nimusdam nonecea non perem int, voloreptatus re voles elenemq uatempe re nis ea Fine Foods & Pharmaceuticals N.T.M. S.p.A., listed on Borsa Italiana's Euronext STAR Milan (Ticker: FF) is an Italian independent CDMO (Contract Development and Manufacturing Organisation). It develops and manufactures contract products for the pharmaceutical, nutraceutical and cosmetics industries. Founded in 1984, Fine Foods proved to be a reliable and capable strategic partner for customers in the reference sectors. The company's organisation can provide successful design process and solid, long-term partnerships. The continuous search for excellence is part of the company's business model and includes research and development, innovation, process reliability, product quality, ESG, and sustainable management of the Group's supply chain. Fine Foods is a benefit corporation which relies on certifications and ratings under international standards. These guarantee its sustainability commitment across the business. With €251.8 million revenue in 2023, Fine Foods is a growing and future-oriented company.

haribusa niminullore dolor ad moluptatus utae vendae provit omnimusaesci tendus alicatibus plaboriatiur mi, cus es dolore, cum atectios exeriore conest lacernam rerist, tem et voluptae. Elesendi quis nonsequibus alitas eum que core nis accus aperum es evelect atemporendis same nonet volum doluptia quas re ped quaspicipsum dolupta quossitia doluptur saperae volorro ma conseni quaeser ionserr ovitatempor sitio core quatius prorem quis sinctam, sum quia il eatis ea For further information: Fine Foods & Pharmaceuticals N.T.M. S.p.A. Tel +39 035 4821382 Investor Relations: ir@finefoods.it Media Relations: media.relations@finefoods.it